Adolescent Binge Drinking Leads to Changes in Alcohol Drinking, Anxiety, and Amygdalar Corticotropin Releasing Factor Cells in Adulthood in Male Rats

por Gilpin, Nicholas W., Karanikas, Chrisanthi A., Richardson, Heather N.
Publicado 2012

Efficacy of Dulaglutide as a First Injectable Option for Patients with Type 2 Diabetes: A Post-Hoc Pooled Analysis

por Patel, Hiren, Munir, Kashif, Sutherland, Sindee, Karanikas, Chrisanthi A., Konig, Manige
Publicado 2019

Effect of once weekly dulaglutide by baseline beta‐cell function in people with type 2 diabetes in the AWARD programme

por Mathieu, Chantal, Del Prato, Stefano, Botros, Fady T., Thieu, Vivian T., Pavo, Imre, Jia, Nan, Haupt, Axel, Karanikas, Chrisanthi A., García‐Pérez, Luis‐Emilio
Publicado 2018

Generalizability of glucagon‐like peptide‐1 receptor agonist cardiovascular outcome trials to the overall type 2 diabetes population in the United States

por Boye, Kristina S., Riddle, Matthew C., Gerstein, Hertzel C., Mody, Reema, Garcia‐Perez, Luis‐Emilio, Karanikas, Chrisanthi A., Lage, Maureen J., Riesmeyer, Jeffrey S., Lakshmanan, Mark C.
Publicado 2019

Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes

por Hartman, Mark L., Sanyal, Arun J., Loomba, Rohit, Wilson, Jonathan M., Nikooienejad, Amir, Bray, Ross, Karanikas, Chrisanthi A., Duffin, Kevin L., Robins, Deborah A., Haupt, Axel
Publicado 2020

Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes

por Heise, Tim, DeVries, J. Hans, Urva, Shweta, Li, Jing, Pratt, Edward J., Thomas, Melissa K., Mather, Kieren J., Karanikas, Chrisanthi A., Dunn, Julia, Haupt, Axel, Milicevic, Zvonko, Coskun, Tamer
Publicado 2023